Recent Finacing
Recent Raise
CONNECTA Therapeutics is a clinical-stage biotech developing AI-designed CTH120 to modulate neuroplasticity for Fragile X and other CNS disorders, completing Phase I and planning Phase IIa.
Focus Areas
Total Raised
Funding round
See the team members at Connecta Therapeutics.
